



Pharmaceuticals | Small Cap
Themis Medicare Ltd demonstrates a mixed financial performance. The company exhibits strengths in solvency and profitability, indicating a stable financial structure and ability to generate profits. Growth metrics are varied, with strong asset and operating profit growth offset by declines in EPS and net income growth. Efficiency ratios, however, need improvement. The company maintains reasonable coverage of its interest expenses. Overall, Themis Medicare shows potential but needs to focus on improving efficiency and ensuring consistent growth across all key metrics to enhance its financial health. The company's ability to manage its debt and generate sufficient profit margins are positive indicators, while inconsistent growth rates and lower efficiency ratios present challenges.
Themis Medicare Ltd demonstrates a mixed financial performance. The company exhibits strengths in solvency and profitability, indicating a stable financial structure and ability to generate profits. Growth metrics are varied, with strong asset and operating profit growth offset by declines in EPS and net income growth. Efficiency ratios, however, need improvement. The company maintains reasonable coverage of its interest expenses. Overall, Themis Medicare shows potential but needs to focus on improving efficiency and ensuring consistent growth across all key metrics to enhance its financial health. The company's ability to manage its debt and generate sufficient profit margins are positive indicators, while inconsistent growth rates and lower efficiency ratios present challenges.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-31.37
Industry Median
19.41
Small Cap Median
18.08
P/E RATIO
28.27
P/B RATIO
2.22
Industry Median
1.98
Small Cap Median
2.03
P/S RATIO
2.08
Industry Median
2.06
Small Cap Median
1.64
Others
PEG RATIO
7.23
EV/EBITDA RATIO
14.13
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹91.61 as on Feb 20, 2026.
The company demonstrates mixed growth performance. While the company has strong operating profit and asset growth, the company experiences negative trends in earnings per share and net income. Balancing growth across all key metrics is essential for sustainable financial improvement. The company shows potential for growth but needs to address inconsistencies to achieve long-term success.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 71 | -10.38 | 7.91 | 6.28 | -15.76 |
| Operating Profit Growth Rate | 95.92 | -30.21 | -22.39 | -5.77 | -100 |
| Earnings Per Share (EPS) Growth | 104.12 | -21.97 | -23.46 | -31.5 | -96.3 |
| Asset Growth Rate | 15.36 | 20.09 | 10.12 | 3.89 | 1.7 |
| Net Income Growth Rate | 102.78 | -21.92 | -22.81 | -31.82 | -96.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Themis Medicare Ltd | 5.39 | 28.27 | Neutral | -42.00 | 3.25 | 40.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Themis Medicare Ltd. is an Indian pharmaceutical company engaged in the manufacturing, marketing, and exporting of active pharmaceutical ingredients (APIs) and finished formulations. It specializes in therapeutic areas such as critical care, anti-infectives, pain management, and women's health. The company serves both domestic and international markets, focusing on high-quality, innovative healthcare solutions.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Themis Medicare Ltd's P/E ratio (TTM) is -31.37, compared to the industry median of 19.41 and large cap median of 18.08.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Themis Medicare Ltd's P/B ratio is 2.22, compared to the industry median of 1.98 and large cap median of 2.03.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Themis Medicare Ltd's P/S ratio is 2.08, compared to the industry median of 2.06 and large cap median of 1.64.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Themis Medicare Ltd's PEG ratio is 7.23.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Themis Medicare Ltd's EV/EBITDA ratio is 14.13.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Themis Medicare Ltd's ROE is 0.25%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Themis Medicare Ltd's ROA is 0%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Themis Medicare Ltd's ROCE is 3%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Themis Medicare Ltd's operating margin is 0%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Themis Medicare Ltd's net margin is 0.29%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Themis Medicare Ltd's current ratio is 1.81.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Themis Medicare Ltd's debt-to-equity ratio is 0.05.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Themis Medicare Ltd's interest coverage ratio is 1.18.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Themis Medicare Ltd's DPS is ₹0.48.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Themis Medicare Ltd's EPS is -96.30.
(Source line: "Ratios as of 22 Nov 2026, based on last traded price of ₹91.61. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1969 (as Themis Pharmaceuticals Private Limited)
Headquarters: Mumbai, Maharashtra
Core Offerings: Active Pharmaceutical Ingredients (APIs), Finished Formulations, Contract Manufacturing, Critical Care products, Specialty Generics
Stock Listing: NSE (THEMISMED), BSE (530199)
Promoter: Shanti G. Patel / Themis Group
1969: Incorporated as Themis Pharmaceuticals Private Limited. 1984: Renamed to Themis Medicare Ltd. 1994: Entered into a joint venture with a European partner for specialized APIs. 2000s: Expanded manufacturing capabilities, establishing multiple state-of-the-art facilities. 2010s: Increased focus on R&D and international registrations, particularly for critical care products. Present: Continues to innovate in pharmaceuticals, serving global markets with a strong presence in various therapeutic segments.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Finished Formulations | N/A | Operating Profit |
| Active Pharmaceutical Ingredients (APIs) | N/A | Operating Profit |
Finished Formulations: Manufactures and markets a wide range of finished dosage forms, including injectables, tablets, and capsules across therapeutic areas such as critical care, anti-infectives, and pain management. These products cater to both domestic and international markets.
Active Pharmaceutical Ingredients (APIs): Engaged in the development and production of various high-quality APIs, which serve as key raw materials for pharmaceutical manufacturing. Focuses on specialized and complex molecules.
Dr. Sachin Shantilal Patel - Chairman & Whole Time Director: A pharmacist by qualification, he has over 30 years of experience in the pharmaceutical industry, playing a pivotal role in the company's growth and strategic direction.
Themis Drugs Private Limited
Themis Pharma Limited (Kenya)
Themis Medicare Inc. (USA)
Bio-Pharma Solutions LLC (USA)
Bonus Issue: 1:4 (1 share for every 4 held) in February 2024.
The Themis Medicare Ltd share price today is ₹91.61 on NSE (THEMISMED), as of 22 Nov 2026.
As of 22 Nov 2026, Themis Medicare Ltd share price is ₹91.61, with previous close ₹91.61. Today's range is ₹91.61 to ₹91.61. The 52-week range is ₹64.95 to ₹140.60.
As of today, Themis Medicare Ltd's market cap is ₹842.81 crore (Small Cap).
Themis Medicare Ltd's current P/E ratio is -31.37, compared to the Pharmaceuticals & Biotechnology sector average of 35.
Themis Medicare Ltd's current P/B ratio is 2.22.
Themis Medicare Ltd's current dividend yield is 0.52%. Last dividend of ₹2.00 per share was declared on 24-May-2024.
Themis Medicare Ltd's EPS (TTM) is ₹-96.30.
Themis Medicare Ltd. is an Indian pharmaceutical company engaged in the manufacturing, marketing, and exporting of active pharmaceutical ingredients (APIs) and finished formulations. It specializes in therapeutic areas such as critical care, anti-infectives, pain management, and women's health. The company serves both domestic and international markets, focusing on high-quality, innovative healthcare solutions.
Themis Medicare Ltd is promoted by Shanti G. Patel / Themis Group, holding 67.11% as of 22 Nov 2026.
Themis Medicare Ltd is listed on NSE (THEMISMED) and BSE (530199). Its next quarterly results are expected on August 2024.